Olympic Wealth Fund Marathon Class 'A' April Fact sheet

1. Marathon Freedom Fund SP Fund Fact Sheet Class A - April 2015
Investment Objective
Marathon Freedom Fund SP is a global equity fund that seeks to offer clients
the benefits from investment techniques which are typically exclusive to large
investment Funds.
The Fund is medium risk and aims to provide capital growth but in a balanced
manner by employing Warren Buffett’s ‘Focus Investing’ approach. This involves
investing in equities from the perspective of buying into a business which is well
run, has a distinct marketing edge and has a high probability of above average
performance.
Thefocusiscurrentlyontheglobalmarketswherewebelievemoreopportunities
exist with a broader mandate.
Cumulative performance % (in denominated currency)
1 month 3 months 1 year 3 years Since launch Launch date
CLASS A -0.04 10.72 160.15 - 135.92 May 2013
Calendar year performance % (in denominated currency)
2009 2010 2011 2012 2013 2014 2015 YTD
CLASS A - - - - -5.46 125.46 12.50%
Top holdings (as at 30 April 2015)
Holdings Sector Region Holdings
Apple Consumer Goods US 27%
Gilead Sciences Inc. Healthcare US 22%
Boston Beer Co Consumer Goods US 22%
Union Pacific Corp Services US 9%
Schlumberger Ltd Basic Materials US 8%
Micron Technology Inc Technology US 6%
PUT Boston Beer Co Consumer Goods US 6%
30000
25000
20000
15000
USD 10,000
initial
investment
USD 23,592
(Growth of
123.6%)
Disclaimer:
The above graph is for ‘illustrative purposes’ only and should not be construed as a
guide to future growth.
The graph below represents the growth of a USD10,000 investment.
Fund details and data at a glance
Minimum Subscription: USD 25,000
Subsequent Investment Minimum: USD 1,000
Initial Fee: Up to 5%
Annual Management Fee: 2%
Performance Fee: 25% (hurdle rate 5%)
Dealing Restriction: Experienced Investors
Asset Manager: Pathway Asset Management
Administrator: Trust Admin UK
Custodian: JP Morgan
Legal Advisor: Harneys Cayman
Auditors: PKF (Cayman)
Dealing/Pricing: Monthly
Dealing Day: 1st day of the month
Launch Date: May 2013
Date: 30 April 2015
Denominated currency & NAV per unit: USD 235.92
SEDOL/ISIN code: KYG674931251
Performance Review
April was a pretty flat month for the major stock market indices. On
average the US indices grew 1.1% while the major European indices were
down 1.0%. On the other hand the Asian markets performed healthily with
an average growth of 10%.
These indicators are a reflection of what is happening in the world
economies today. US markets tend to portray modest growth; the
European economies are suffering from the effects of the financial strain of
Greek debt woes. The Asian economies continue to have expansive growth
though being a risk on investment region.
During the month we added Gilead science Inc. (GILD) on a downward
dip and that has paid off handsomely. Gilead is one of the leading
biopharmaceutical manufacturers of antiviral drugs for the treatment of
the human immunodeficiency virus (HIV) as well as a leader in producing
liver disease drugs to fight hepatitis B and C viruses. The efficacy of their
liver disease drug (Harvoni) is said to have 96- 99% cure rate in just 12
weeks of therapy and has been the driving force behind their recent stock
price ascent. We believe we bought at an opportune time and are poised
to benefit from this future growth.
In conclusion; we will maintain a cautious outlook for May and June as
these months are considered to be the selling months, where trading
activity is based on seasonal “emotional” selling rather than analytical
and empirical information of the equity markets. Similarly if any buying
opportunities should present themselves we will acquire appropriately.
Asset Manager: Pathway Asset Management
Direct Line: +44 (0) 203 755 3457
Dealing Fax: +44 (0) 207 170 4001
Email: enquiries@pathwayam.pro
Address: Winchester House
259-269 Old Marylebone Rd, London, NWI 5RA
Olympic Wealth Fund SPC
This fact sheet and the information it contains has been produced by Olympic Wealth Management in
conjunction with the Fund Manager, Pathway Asset Management with the aim of providing information
to current and prospective investors to the Fund.
It should be noted that this fact sheet itself, does not represent an offering and should be read in
conjunction with the Fund’s Offering Memorandum which provides detailed information on the Fund
including investment type, investment strategy and leverage limits. Please note that past performance
does not guarantee future payments and that the value of the income derived from investments may
fluctuate up or down and investors into the Fund may not get back their original investment.
Further information regarding Marathon Freedom Fund SP Fund can be obtained from the Offering
Memorandum document available on our website: www.olympicwealth.com
Disclaimer
Class A: Investment performance since inception in May 2013
Class A: Growth of a USD10,000 investment since inception in May 2013
20000
18000
16000
14000
12000
10000
USD 10,000
initial
investment
CLASS A: Growth of a USDl0,000 investment since
inception in July 2011
USD 18,981
(Growth of
90%)